Stay updated on Psilocybin vs Niacin for Depression Clinical Trial
Sign up to get notified when there's something new on the Psilocybin vs Niacin for Depression Clinical Trial page.

Latest updates to the Psilocybin vs Niacin for Depression Clinical Trial page
- ChecktodayChange DetectedA banner announces NIH’s transition to using “Super Intelligence” instead of “Artificial Intelligence.” It appears above a page displaying a 403 error rather than the study record.SummaryDifference1%

- Check7 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2; the study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check35 days agoChange DetectedA new revision tag (Revision: v3.7.0) is shown, and a substantial amount of boilerplate UI text and metadata was removed, simplifying the page without altering the essential study information.SummaryDifference15%

- Check56 days agoChange DetectedThe page shows a new site revision tag, Revision: v3.6.6, replacing Revision: v3.6.5. This indicates a software update or patch was applied to the site.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page now displays a new revision tag (v3.6.5) replacing the previous tag (v3.6.4), indicating a minor update to the page's revision metadata. This does not change the study content or user-facing data presented on the page.SummaryDifference0.1%

Stay in the know with updates to Psilocybin vs Niacin for Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin vs Niacin for Depression Clinical Trial page.